Citable company snapshot
Steris's latest SEC-sourced 2026-03-31 period shows $1.59B in revenue and $220.10M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $1.59B | $1.50B | +6.2% |
| xbrl:GrossProfit | Mar 31, 2026 | $697.10M | $655.50M | +6.3% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $316.80M | $273.20M | +16.0% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $220.10M | $192.90M | +14.1% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $335.40M | $298.20M | +12.5% |
| Free Cash Flow (computed) | Mar 31, 2026 | $245.20M | $199.50M | +22.9% |
Source: SEC EDGAR, derived from filed XBRL; period Mar 31, 2026; filed May 29, 2026; accession 0001628280-26-039136.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
